AMNEAL PHARMACEUTICALS, INC. Estimated Litigation Liability, Current
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Estimated Litigation Liability, Current of $18.49 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LitigationReserveCurrent · last filed 2026-08-06
- 2026-06-30: Estimated Litigation Liability, Current $18.49M.
- 2026-03-31: Estimated Litigation Liability, Current $10.55M.
- 2025-12-31: Estimated Litigation Liability, Current $43.26M.
- 2025-09-30: Estimated Litigation Liability, Current $40.60M.
| Period end | Estimated Litigation Liability, Current |
|---|---|
| 2026-06-30 | $18.49M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $10.55M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $43.26M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $40.60M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $41.52M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $43.50M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $31.75M 10-K · filed 2026-02-27 |
| 2024-09-30 | $30.18M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $30.74M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $30.13M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $76.99M 10-K · filed 2025-02-28 |
| 2023-09-30 | $76.83M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $77.01M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $76.32M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $107.48M 10-K · filed 2024-03-14 |
| 2022-09-30 | $176.09M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $275.34M 10-Q · filed 2022-08-08 |
| 2021-12-31 | $58.00M 10-K · filed 2023-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |